World wide shipping
Medicines from all over the world
We will help you find any drug in 24 hours
Prices for medicines are presented for informational purposes only

Imbruvica (ibrutinib) 140 mg 90 tabs JANSEN Switzerland

Article:
In Stock
0 $
1 980 $
Description

Indications:

  • Imbruvica is indicated for the treatment of mantle-clitinous lymphoma in adult patients who have relapsed or have not responded to previous treatment.
  • Imbruvica is indicated for the treatment of chronic lymphocytic leukemia in adult patients who have received at least one course of treatment, or as first-line therapy for patients with a 17p deletion or TP53 mutation in patients who are not eligible for chemoimmunotherapy.
  • 4800ct
Features
  • Commercial name:
    Imbruvik
  • Сhemical name:
    Ibrutinib
  • Dosage:
    140 mg
  • Quantity:
    90
  • Release form:
    Tablets
Reviews
No reviews yet
Write Review
Name*
Email
Write a Review*